Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Halozyme Provides Update Following Type B FDA Meeting
Halozyme Provides Update Following Type B FDA Meeting
Halozyme Provides Update Following Type B FDA Meeting
Submitted by
admin
on April 8, 2015 - 10:44am
Source:
Yahoo
News Tags:
Halozyme
FDA
PEGPH20
pancreatic cancer
Headline:
Halozyme Provides Update Following Type B FDA Meeting
Do Not Allow Advertisers to Use My Personal information
